HygienePhase 4NCT00881270
Dermacyd Infantile - Acceptability.
A Phase 4 study testing LACTIC ACID(ND) in people with Hygiene, run by Sanofi at 1 site in Brazil.
Trial summary
Primary Objective: To prove the safety of the formulation in normal conditions of use. Read more about this study
- Who is it for?
- Ages Up to 12 yearsHealthy volunteers can take part
- Conditions the study is for
- Hygiene
- What is being tested?
- LACTIC ACID(ND)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 31 participants
- Where
- 1 siteBrazil
- Study dates
- Mar 2009to Mar 2009
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 12 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Integral skin test in the region
- Use the same category of cosmetics
- Willingness in following the study procedures and to be present in the clinic at the days and scheduled time.
Who cannot join
- Use of Anti-inflammatory, immunosuppressant or anti-histaminic drugs
- Allergic or atopic history to cosmetics products
- Cutaneous active disease (local or general) in the evaluated area
- Disease which can cause immunosuppressant, such as diabetes, HIV
- Endocrine pathology
- Intensive solar exposure until 15 days before evaluation
- Treatment four months before selection.
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Safety Dermatological Evaluation: Acceptability With Paediatric Follow up Dermacyd Infantile (Lactic Acid).
Primary Objective:
To prove the safety of the formulation in normal conditions of use.
- Conditions
- Hygiene
- Being tested
- LACTIC ACID(ND)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
LACTIC ACID(ND)Drug
Dermacyd Infantile (LACTIC ACID)
| Study group | Role | What they receive |
|---|---|---|
| Dermacyd infantile (Lactic Acid) | Experimental | treatment duration 21 consecutive days Receives: Drug: LACTIC ACID(ND) |
What is being measured
The primary outcome is the main question the study is designed to answer.
The absence of irritation and the good acceptability will be evaluated using one specific scale which describes the intensity of the reaction.
Measured: From the treatment start to the end of the study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Apr 2009 (estimated)
- Study startMar 2009
- Primary completionMar 2009
- Study completionMar 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HygieneStudies of the same condition, open and under way.
- More trials run by SanofiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sanofi
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Jaderson Lima, Study director, Sanofi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00881270
- Sponsor's protocol ID
- LACAC_L_04678
- Status last verified
- Sep 2009
- First submitted
- 10 Apr 2009
- Last updated
- 28 Sep 2009
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Sep 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Safety Dermatological Evaluation: Acceptability With Paediatric Follow up Dermacyd Infantile (Lactic Acid).
- ClinicalTrials.gov ID
- NCT00881270
- Acronym / sponsor ID
- LACAC_L_04678
- Conditions
- Hygiene
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- SanofiIndustry (pharma, biotech, devices)
- Study start
- Mar 2009
- Primary completion
- Mar 2009 (actual)
- Study completion
- Mar 2009 (actual)
- First posted
- 15 Apr 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Primary Objective:
To prove the safety of the formulation in normal conditions of use.
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Dermacyd infantile (Lactic Acid) | Experimental | Drug: LACTIC ACID(ND)treatment duration 21 consecutive days |
Who may qualify
- Ages
- Up to 12 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- Integral skin test in the region
- Use the same category of cosmetics
- Willingness in following the study procedures and to be present in the clinic at the days and scheduled time.
Key exclusion criteria (8 listed)
- Use of Anti-inflammatory, immunosuppressant or anti-histaminic drugs
- Allergic or atopic history to cosmetics products
- Cutaneous active disease (local or general) in the evaluated area
- Disease which can cause immunosuppressant, such as diabetes, HIV
- Endocrine pathology
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| LACTIC ACID(ND)Dermacyd Infantile (LACTIC ACID) | Drug | Dermacyd infantile (Lactic Acid) |
Primary outcome
The absence of irritation and the good acceptability will be evaluated using one specific scale which describes the intensity of the reaction.
Time frame: From the treatment start to the end of the study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Sep 2009.
Related trials for Hygiene
Recruiting
Climate-Responsive Nutrition, WASH, and Heat Counselling for Maternal and Child Health in Sindh, Pakistan
Maternal Nutrition, Child Nutrition
Not yet recruitingObservational study
Development of a Body Hygiene Assessment Scale for Bedbound Individuals
Body Hygiene Status in Bedbound Individuals
Not yet recruiting
Effectiveness of Oil Pulling Using Oils in Comparison With Mouthwash for Gingivitis
Gingivitis
Not yet recruiting
AI-Powered Sleep Hygiene Mentor for Adults Living With HIV
Sleep Wake Disorders, Sleep Initiation and Maintenance Disorders
RecruitingObservational study
Primitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene Products
Primary Immune Deficiency Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jaderson Lima study director
Sanofi
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing LACTIC ACID(ND) in people with Hygiene, run by Sanofi at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Sep 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The absence of irritation and the good acceptability will be evaluated using one specific scale which describes the intensity of the reaction. (time frame: From the treatment start to the end of the study). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2009.